Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328
Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income areas. The vaccine targets poly N-acetyl glucosamine found on various pathogens. Pre-clinical studies showed its effectiveness against over 15 pathogens, and a phase I trial confirmed its safety.
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Bharat Biotech has teamed up with Alopexx Inc to co-develop and market the broad-spectrum antimicrobial vaccine AV0328 in India and other low-income areas. The vaccine targets poly N-acetyl glucosamine found on various pathogens. Pre-clinical studies showed its effectiveness against over 15 pathogens, and a phase I trial confirmed its safety. 
